Literature DB >> 12657597

A new topical model of Staphylococcus corneal infection in the mouse.

Dalia O Girgis1, Gregory D Sloop, Julian M Reed, Richard J O'Callaghan.   

Abstract

PURPOSE: To establish, in the scarified mouse eye, a new model of Staphylococcus aureus keratitis suitable for studies of pathogenesis and host defense mechanisms.
METHODS: Corneas of three strains of mice (BALB/c, A/J, and C57BL/6) were scarified and inoculated with S. aureus strain 8325-4. Mice underwent slit lamp examination (SLE) at 1, 3, 5, 7, and 9 days after infection and were killed. Histopathologic analyses, determination of bacterial colony-forming units (CFU), and myeloperoxidase (MPO) activity assays were performed at each time point.
RESULTS: S. aureus keratitis developed in both BALB/c and A/J strains of mice, but not in C57BL/6. The BALB/c and A/J strains demonstrated greater susceptibility to infection, as evidenced by significantly higher SLE scores and more viable bacteria per infected eye than in C57BL/6 mice at 5, 7, and 9 days after infection (P <or= 0.0001). Histopathologic analysis and MPO assays of infected A/J mice both revealed an influx of polymorphonuclear leukocytes (PMNs). Histology demonstrated presence of leukocytes in the aqueous humor, migration of PMNs into infected tissue, corneal erosion, and edema in the eyes of infected A/J mice. Whereas infected BALB/c mice demonstrated both PMN migration and corneal edema, eyes of infected C57BL/6 mice failed to show even mild histopathologic changes.
CONCLUSIONS: These studies demonstrate the establishment of Staphylococcus keratitis in the mouse eye. This model should provide for a large range of future studies that are currently unavailable in the rabbit keratitis model, particularly those requiring a genetically altered host or specific immunologic reagents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657597     DOI: 10.1167/iovs.02-0656

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

Review 1.  Toll-like receptors in ocular surface disease.

Authors:  Rachel L Redfern; Alison M McDermott
Journal:  Exp Eye Res       Date:  2010-03-24       Impact factor: 3.467

2.  CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis.

Authors:  Michelle Lin; Eric Carlson; Eugenia Diaconu; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2006-11-16       Impact factor: 4.962

3.  Acute systemic immune activation following conjunctival exposure to staphylococcal enterotoxin B.

Authors:  Govindarajan Rajagopalan; Michele K Smart; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Viral infection of the lungs through the eye.

Authors:  Vira Bitko; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

5.  Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.

Authors:  Aihua Tang; Armando R Caballero; Mary E Marquart; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-17       Impact factor: 4.799

6.  Development of a Streptococcus pneumoniae keratitis model in mice.

Authors:  Quincy C Moore; Clare C McCormick; Erin W Norcross; Chinwendu Onwubiko; Melissa E Sanders; Jonathan Fratkin; Larry S McDaniel; Richard J O'Callaghan; Mary E Marquart
Journal:  Ophthalmic Res       Date:  2009-07-23       Impact factor: 2.892

Review 7.  Toll-like receptors at the ocular surface.

Authors:  Eric Pearlman; Angela Johnson; Gautam Adhikary; Yan Sun; Holly R Chinnery; Todd Fox; Mark Kester; Paul G McMenamin
Journal:  Ocul Surf       Date:  2008-07       Impact factor: 5.033

8.  C-Jun NH2 terminal kinase (JNK) is an essential mediator of Toll-like receptor 2-induced corneal inflammation.

Authors:  Gautam Adhikary; Yan Sun; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2008-01-24       Impact factor: 4.962

9.  A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye.

Authors:  Alla Musiyenko; Lucia Correa; Nicholas Stock; John H Hutchinson; Daniel S Lorrain; Gretchen Bain; Jilly F Evans; Sailen Barik
Journal:  Clin Vaccine Immunol       Date:  2009-09-16

10.  Emodin ameliorates lipopolysaccharides-induced corneal inflammation in rats.

Authors:  Guo-Ling Chen; Jing-Jing Zhang; Xin Kao; Lu-Wan Wei; Zhi-Yu Liu
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.